cyclophosphamide; 50-18-0; Cytoxan; Cyclophosphamid; Cyclophosphane; Endoxan; Cytophosphan; Procytox; Sendoxan; Clafen; Cyclophosphan; Cyclostin; Cyclophosphamidum; Cytophosphane; Endoxanal; Neosar; Claphene; Endoxana; Genoxal; Endoxan-Asta; Endoxan R; Zyklophosphamid; Mitoxan; Cyclophosphoramide; Cyklofosfamid; Endoxane; (RS)-Cyclophosphamide; Cyclophosphamide anhydrous; Cyclophosphanum; Enduxan; Semdoxan; Senduxan; (+-)-Cyclophosphamide; Ciclophosphamide; ASTA; Lyophilized Cytoxan; Ciclofosfamida; D,L-Cyclophosphamide; Rcra waste number U058; Asta B 518; (-)-Cyclophosphamide; Cycloblastin; NSC-26271; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; CB 4564; Cyclophosphamide (anhydrous); NCI-C04900; ASTA B518; SK 20501; NSC 26271; CHEBI:4027; B 518; Occupation, cyclophosphamide exposure; CCRIS 188; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; 4-Hydroxy-cyclophosphan-mamophosphatide; HSDB 3047; Anhydrous cyclophosphamide; EINECS 200-015-4; Ciclofosfamide; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; UNII-6UXW23996M; BRN 0011744; Cyclophosphamide-d4; AI3-26198; 6UXW23996M; Cyclophosphamide (INN); 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin; NSC26271; Cytoxan (TN); 2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide; N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide; N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide; 50-18-0 (anhydrous); 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-,2-oxide; Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester; CY; DTXSID5020364; CYCLOPHOSPHAMIDE LYOPHILIZED; CYCLOPHOSPHAMIDE, ANHYDROUS; N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide; 2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazophosphorine 2-oxide; N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide; Cyklofosfamid [Czech]; N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine; N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid; Ciclophosphamide [INN]; 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide; Zyklophosphamid [German]; NSC-756711; Ciclophosphamide hydrat; Cytoxan (Lyophilized); CYCLOPHOSPHAMIDE [INN]; Ciclofosfamida [INN-Spanish]; Cyclophosphamidum [INN-Latin]; UNII-8N3DW7272P; CYCLOPHOSPHAMIDE (IARC); CCRIS 7469; CYCLOPHOSPHAMIDE (USP-RS); Cyclophosphamide (anhydrous form); Cyclophosphamide (TN); CYCLOPHOSPHAMIDE (EP MONOGRAPH); CYCLOPHOSPHAMIDE (USP MONOGRAPH); SR-01000075737; NCGC00015209-05; RCRA waste no. U058; Cyclophosphamide [USP:INN]; Cycloblastine; Cyclofosphamide; Cyclophospham; Cyclostine; Fosfaseron; Syklofosfamid; Carloxan; Cicloxal; Genuxal; Ledoxina; 2-(Bis(2-chloroethyl)amino)-2H-1,2-oxazaphosphorine 2-oxide; 2-[Bis(2-chloroethyl)amino]-2H-1,2-oxazaphosphorine 2-oxide; 2-(Bis(2-chloroethylamino))-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide; (Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate; [Bis(chloro-2-ethyl)amino]-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate; 2-(BIS(2-CHLOROETHYL)AMINO)TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE; CYCLO-cell; N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum; 173547-45-0; bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; CB-4564; Spectrum_000858; CHEMBL88; Spectrum2_001146; Spectrum3_000370; Spectrum4_000304; Spectrum5_000795; Lopac-C-0768; Epitope ID:131782; C 0768; N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid [German]; SCHEMBL4346; (.+/-.)-Cyclophosphamide; Lopac0_000238; BSPBio_002099; KBioGR_000888; KBioSS_001338; DivK1c_000246; DTXCID70364; SPBio_001071; CYCLOPHOSPHAMIDE [HSDB]; GTPL7154; SCHEMBL4345553; 2-H-1,3,2-Oxazaphosphorinane; SCHEMBL10262910; CMSMOCZEIVJLDB-UHFFFAOYSA-; KBio1_000246; KBio2_001338; KBio2_003906; KBio2_006474; KBio3_001319; CYCLOPHOSPAMIDE MONOHYDRATE; CYCLOPHOSPHAMIDE [WHO-DD]; L01AA01; WLN: T6MPOTJ BO BN2G2G; NINDS_000246; 2-(bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide; HMS2090A12; HMS3260P17; HMS3715J05; Pharmakon1600-01500213; AMY33449; BCP02139; Tox21_500238; BDBM50237604; N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine; NSC273033; NSC273034; NSC756711; STK177249; AKOS005410738; tetrahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; CS-1425; CYCLOPHOSPHAMIDE ANHYDROUS [MI]; DB00531; LP00238; NSC-273033; NSC-273034; SDCCGSBI-0050226.P004; IDI1_000246; N,3,2-oxazaphosphorin-2-amine-2-oxide; N,O-propylen-phosphorsaeure-ester-diamid; NCGC00015209-01; NCGC00015209-02; NCGC00015209-03; NCGC00015209-04; NCGC00015209-06; NCGC00015209-07; NCGC00015209-08; NCGC00015209-09; NCGC00015209-12; NCGC00015209-28; NCGC00091741-02; NCGC00091741-03; NCGC00260923-01; AS-73255; BP-25411; HY-17420; NCI60_002097; N,O-propylenephosphoric acid ester diamide; SBI-0050226.P003; DB-082057; N,O-propylene-phosphoric acid ester diamide; WR-138719; C2236; EU-0100238; FT-0624276; FT-0665387; N,O-trimethylenephosphoric acid ester diamide; NS00000339; EN300-74526; C07888; D07760; AB00053446-09; AB00053446-11; AB00053446-12; AB00053446_13; AB00053446_14; AB00053446_15; Q408524; W-60377; N,O-propylenephosphoric acid ester amide monohydrate; SR-01000075737-1; SR-01000075737-6; W-105248; BRD-A09722536-002-02-4; Z276509078; 2-(bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane2-oxide; Bis(2-chloroethyl)phosphoramide-cyclic propanolamide ester; 2-[bis(2-chloroethyl)amino]-1,3,2??-oxazaphosphinan-2-one; 1-BIS(2-CHLOROETHYL)AMINO-1-OXO-2-AZA-5-OXAPHOSPHORIDINE; 2-[bis(2-chloroethyl)amino]-1,3,2$l^{5}-oxazaphosphinan-2-one; 2-[bis(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide #; 2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide; 2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide; 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide; N,N-Bis(.beta.-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide; N,N-Bis-(.beta.-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid; N,N-DI(2-CHLOROETHYL)-N,O-PROPYLENE PHOSPHORIC ACID ESTER DIAMIDE; (+/-)-2-(BIS(2-CHLOROETHYL)AMINO)TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE; 2-(DI(2-CHLOROETHYLAMINO))-1-OXA-3-AZA-2-PHOSPHACYCLOHEXANE 2-OXIDE; 2-Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide; 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide; 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+)-; 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (-)-; 2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate; 2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide; N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine; N,N-BIS(2-CHLOROETHYL)-N'-(3-HYDROXYPROPYL)PHOSPHORODIAMIDIC ACID INTRAMOL.; N,N-BIS(BETA-CHLOROETHYL)N',O-TRIMETHYLENEPHOSPHORIC ACID ESTER DIAMIDE; Phosphorodiamidic acid,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester; InChI=1/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)